状态患者的低剂量和对药物治疗的反应:沙特阿拉伯的一项回顾性研究
Sultan M Alghadeer1, Aseel Alsuwayegh2, Hessa AlMuqati3
1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Annals of medicine
|May 3, 2025
概括
这项研究强调,抗发作药物 (ASM) 在沙特阿拉伯治疗状态 (SE) 方面比 benzodiazepines (BDZs) 更有效. 低剂量的BDZs是常见的,与治疗失败有关,强调需要更好的管理协议.
科学领域:
- 神经学 神经学
- 紧急医疗 紧急医疗
- 临床药理学 临床药理学
背景情况:
- 了解状态 (SE) 模式和优化治疗至关重要,但沙特人口的数据有限.
- 这项研究解决了在沙特阿拉伯对SE管理的本地化数据的需求.
研究的目的:
- 描述入住急诊室 (ED) 的SE.的成年患者的特征.
- 分析用于SE的药物治疗模式.
- 评估治疗反应,并确定治疗失败的原因在SE管理.
主要方法:
- 从2015年5月到2021年7月,在两家沙特医院进行了一项回顾性研究.
- 包括420个SE发作在成年患者接受类药物 (BDZs) 或抗发作药物 (ASM) 在ED.
- 分析了患者的人口统计,治疗方案,反应率和与治疗结果相关的因素.
主要成果:
- 抗发作药物 (ASM) 的反应率明显高 (79.1%),相比于类药物 (BDZs) (24.8%).
- 低剂量在BDZ中比ASM (19.6%) 更频繁 (63.4%),并且与治疗失败有很强的相关性.
- 患有史的患者占研究人群的89.0%.
结论:
- 需要加强医生教育,提高药物监管意识,并严格遵守沙特阿拉伯SE管理的临床指南.
- 优化药物治疗,包括适当的剂量,对于改善SE患者的治疗结果至关重要.
相关概念视频
Factors Affecting Drug Response: Overview
1.6K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.6K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
31
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
31
Pharmacovigilance
735
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
735
Drug Dosage Regimen: Overview
3.3K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.3K
Desensitization and Tachyphylaxis
1.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.4K
Antiepileptic Drugs: Potassium Channel Activators
119
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
119


